Beta(2)-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma

Citation
Sv. Rajkumar et al., Beta(2)-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma, BONE MAR TR, 23(12), 1999, pp. 1261-1266
Citations number
33
Categorie Soggetti
Hematology,"Medical Research Diagnosis & Treatment
Journal title
BONE MARROW TRANSPLANTATION
ISSN journal
02683369 → ACNP
Volume
23
Issue
12
Year of publication
1999
Pages
1261 - 1266
Database
ISI
SICI code
0268-3369(199906)23:12<1261:BABMPC>2.0.ZU;2-K
Abstract
We studied the prognostic value of clinical and laboratory variables, measu red before blood cell transplantation, in predicting complete response amon g patients undergoing autologous blood cell transplantation for relapsed or primary refractory myeloma, Sixty-seven patients who underwent transplanta tion for relapsed or primary refractory myeloma were studied. The overall r esponse rate was 90%, and the complete response rate was 33%, Low beta(2)-m icroglobulin (less than or equal to 2.7 mg/l) was associated with a signifi cantly better complete response rate compared with high levels (54 vs 19%, P = 0.002). Similarly, the complete response rate was 39% when the bone mar row plasma cell percentage was low (<40%) and 21% with greater involvement (P = 0.04), Complete response rate was 50% when beta(2)-microglobulin and b one marrow plasma cell percentage were low, 36% if either was high, and 12% when both were high (P = 0.01). Median survival measured from initial diag nosis of myeloma was 51 months. Overall survival after transplantation was better among responders who achieved complete response than those who did n ot: median survival, 24 vs 11 months, P = 0.04 (log-rank) and 0.009 (Gehan- Wilcoxon). Attainment of a complete response independently predicted better survival in a multivariate analysis. beta(2)-Microglobulin and bone marrow plasma cell percentage predict complete responders among patients undergoi ng transplantation for myeloma.